Inventiva (IVA) Accounts Payables (2018 - 2025)
Inventiva's (IVA) quarterly Accounts Payables came in at $30.3 million in Q4 2025, down 13.76% year-on-year from $35.1 million in Q4 2024, and down 99.92% quarter-over-quarter from $39.3 billion in Q2 2025.
Inventiva (IVA) Accounts Payables (2018 - 2025) Analysis & Trends
Inventiva's Accounts Payables history runs 8 years deep, the most recent figure standing at $30.3 million for Q4 2025.
- On a quarterly basis, Accounts Payables fell 13.76% year-over-year to $30.3 million in Q4 2025; TTM through Dec 2025 was $30.3 million, a 13.76% decrease from a year earlier, with the FY2025 full-year figure at $30.3 million, down 13.76% from the prior year.
- Accounts Payables eased to $30.3 million in Q4 2025 per IVA's latest filing, from $39.3 billion in the prior quarter.
- Across five years, Accounts Payables topped out at $39.3 billion in Q2 2025 and bottomed at $10.4 million in Q4 2023.
- The 5-year median for Accounts Payables is $30.8 million (2023), against an average of $4.6 billion.
- Across the five-year window, Accounts Payables surged 123896.19% in 2022 and sank 99.79% in 2023, its largest moves.
- Year by year, Accounts Payables stood at $16.7 million in 2021, then rose by 18.24% to $19.8 million in 2022, then soared by 105.26% to $40.5 million in 2023, then fell by 13.38% to $35.1 million in 2024, then slipped by 13.76% to $30.3 million in 2025.
- Per Business Quant, the three latest IVA Accounts Payables figures stand at $30.3 million (Q4 2025), $39.3 billion (Q2 2025), and $35.1 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | Inventiva | 842.48 Mn | 842.48 Mn | - | 30.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 30.28 Mn |
| Jun 30, 2025 | 39.28 Bn |
| Dec 31, 2024 | 35.12 Mn |
| Jun 30, 2024 | 40.58 Mn |
| Dec 31, 2023 | 40.54 Mn |
| Oct 11, 2023 | 10.40 Mn |
| Jun 30, 2023 | 31.24 Mn |
| Dec 31, 2022 | 19.75 Mn |
| Jun 30, 2022 | 15.21 Bn |
| Dec 31, 2021 | 16.70 Mn |
| Jun 30, 2021 | 12.27 Mn |
| Mar 31, 2021 | 10.48 Mn |
| Dec 31, 2020 | 8.25 Mn |
| Jun 30, 2020 | 9.39 Mn |
| Dec 31, 2019 | 8.29 Mn |
| Dec 31, 2018 | 9.56 Mn |